Clinical Trial Update: Pre-emptive Hemodynamic Optimization of High Risk Patients Undergoing Elective Major Surgical Procedures [NA]

View source ↗

Summary

The clinical trial investigating pre-emptive hemodynamic optimization in high-risk patients undergoing elective major surgical procedures has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhage

Snippet

Sponsor: University of Pittsburgh | Conditions: Hemorrhage | NA | Status: WITHDRAWN